Medco: Poor adherence may cause lack of response to medication
BOSTON When a patient isn’t showing a response to a medication, a common tactic the doctor might use is to increase the dosage. According to a new study, however, the ineffectiveness might be happening because the patient isn’t properly taking the medication.
The Medco Research Institute, the research arm of pharmacy benefit manager Medco Health Solutions, found that nearly one-third of patients given increased dosages of antidepressants were not regularly taking their original prescriptions. Data from the study recently were presented at the American Psychiatric Association’s 62nd Institute on Psychiatric Services in Boston.
Medco said the study showed doctors should monitor a patient’s adherence to their antidepressants before raising the dosage because poor adherence may contribute to disease relapse, thus leading to unnecessary dosage increases.
“A physician usually increases a dose when a patient is not responding to the current dosage,” Medco Neuroscience Therapeutic Resource Center national practice leader and lead study author David Muzina said. “But the analysis shows that the reason the dose may not be effective is that many patients are not taking their antidepressants as directed.”
BI, Latino Commission on AIDS launch website
RIDGEFIELD, Conn. Drug maker Boehringer Ingelheim and the Latino Commission on AIDS have launched a website targeted at Latinos living with HIV, the two announced Thursday.
The website, MenteCuerpoHAART.com, is a Spanish-language version of an already existing English-language version, MindBodyHAART.com. The site is designed to help patients, their families and doctors understand issues affecting health care and treatment of HIV and find resources on prescribed medications and clinical trials, and communicate with medical providers.
“We face many health challenges in our communities,” Latino Commission on AIDS president Guillermo Chacon said. “It is important that we respond to the crisis of HIV/AIDS, perpetuated by the stigma, poverty, immigration status, fear, access to health care and barriers related to language.”
Tiger Balm sponsors Susan G. Komen Miami/Ft. Lauderdale Race for the Cure
HAYWARD, Calif. Prince of Peace Enterprises on Thursday announced its sponsorship of the 15th annual Susan G. Komen Miami/Ft. Lauderdale Race for the Cure under its Tiger Balm external analgesic brand.
“Tiger Balm stands with Susan G. Komen for the Cure in support of those who have been affected by breast cancer,” stated Kenneth Yeung, Prince of Peace president. “We are proud to sponsor the 15th anniversary of the Miami/Ft. Lauderdale race and to use our involvement to help raise awareness of this important cause among fans and users of Tiger Balm products.”
The Miami/Ft. Lauderdale Komen Affiliate’s service area covers Miami-Dade, Broward and Monroe counties. Up to 75% of the Affiliate’s net income goes toward funding grants to local hospitals, clinics and community organizations that provide breast health education and breast cancer screening and treatment programs for medically underserved women. The remaining net income supports the national Komen Grants Program, which funds groundbreaking breast cancer research, meritorious awards, and educational and scientific programs around the world.
Tiger Balm representatives will distribute free samples of Tiger Balm neck and shoulder rub and free workout towels featuring the Susan G. Komen and Tiger Balm logos at the race. Visitors also can receive free T-shirts with the Tiger Balm logo. Tiger Balm also is sponsoring a photo booth kiosk where individuals or groups can pose for free souvenir photos to mark the significance of the day.